Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Exelint International, Co.

United States·US-MF-000037396

Last updated September 17, 2026

What Exelint International, Co. makes

Exelint International, Co. manufactures single-use medical devices including hypodermic needles, manual scalpel blades, dermal curettes, and scalpels. Their product portfolio also includes disposable syringes, injection plugs, IV sets, IV cannulas with injection ports, biopsy punches, and anesthesia sets.

The company's devices are classified as Class I, Class II, Class III, and Class IIa, and are listed in the EUDAMED and FDA 510(k) registries. Exelint International, Co. is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What medical devices does Exelint International, Co. manufacture?

Exelint International, Co. produces single-use medical devices including hypodermic needles, manual scalpel blades, dermal curettes, scalpels, disposable syringes, injection plugs, IV sets, IV cannulas with injection ports, biopsy punches, and anesthesia sets.

Where is Exelint International, Co. based?

Exelint International, Co. is based in the United States, as indicated in the provided device data.

Which regulatory registries list Exelint International, Co.'s devices?

Exelint International, Co.'s devices are listed in the EUDAMED and FDA 510(k) registries, as specified in the device data.

How are Exelint International, Co.'s devices classified?

Exelint International, Co.'s devices are classified as Class I, Class II, Class III, and Class IIa, according to the regulatory classifications provided in the device data.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
2500, Santa Fe Ave., Redondo Beach, United States
Phone
+1-310-649-0707
PRRC Contact
Vu Doan
EUDAMED SRN
US-MF-000037396
FDA FEI Number
1035907
DUNS Number
—

Catalogue (312)

Page 7 of 7
DeviceModel / ReferenceRegistriesClassStatus
Exel Biopsy Punch, Ss, 7.0mm 29569
EUDAMEDFDA UDI
Class IIaActive
EXEL 2-3mL SYR ONLY L-L 26200
EUDAMEDFDA UDI
Class IActive
EXEL 1/2mL INS 28GX1/2" 26032
EUDAMEDFDA UDI
Class IIaActive
EXEL Aluminum Hub Needles 18G X 5/8" 26463B
EUDAMEDFDA UDI
Class IIaActive
Exel Psv/M-S, L-A 23gx3/4" 26766
EUDAMED
Class IIaActive
EXEL AmLUJECT DENTAL NDL. 27G X 21MM SHORT JP-MF-000026759
EUDAMEDFDA UDI
Class IIaActive
EXEL Hypodermic Needle 25G x 5/8" 26403
EUDAMED
Class IIaActive
Exel, Exeflon 22g Iv Cannula W/ Injection Port 26596
EUDAMED
Class IIaActive
Exel Dermal Curette, Ss, 7.0mm 29584
EUDAMEDFDA UDI
Class IIaActive
EXEL 2-3mL AMBER SYR ONLY L-L W/ TIP CAP 26209
EUDAMEDFDA UDI
Class IActive
Exel, Exeflon 17g Iv Cannula W/ Injection Port 26523
EUDAMED
Class IIaActive
EXEL 2-3mL SYR 18GX1-1/2" 26110
EUDAMEDFDA UDI
Class IIaActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (3)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Exelint International, Co. has 3 recall records, all initiated on 2009-12-23 and terminated. The recalls were for non-coring needles that were shown to core the silicone port's septum, which may lead to decreased effectiveness of the port, infection, necrosis, swelling, and embolization, potentially resulting in pulmonary embolism, limb ischemia, stroke, or local extravasation of medication.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Dec 23, 2009Z-0638-2010—terminated

Non-coring needles that, when inserted into an implanted port, were shown to core the silicone port's septum. Coring of port's septum may lead to: decreased effectiveness of port, infection, necrosis, swelling, and embolization, which may result in pulmonary embolism, limb ischemia, stroke, local extravasation of medication such as chemotherapy or other caustic material; may lead to local tissue

Dec 23, 2009Z-0639-2010—terminated

Coring of port's septum, which may lead to: Decreased effectiveness of port, infection, necrosis, swelling, and embolization, which may result in Pulmonary Embolism, Limb ischemia, stroke, local extravasation of medication such as chemotherapy or other caustic material, may lead to local tissue necrosis, granulomas, failure to deliver therapy, need for additional surgery to replace implanted port

Dec 23, 2009Z-0640-2010—terminated

Coring of port's septum, which may lead to: Decreased effectiveness of port, infection, necrosis, swelling, and embolization, which may result in Pulmonary Embolism, Limb ischemia, stroke, local extravasation of medication such as chemotherapy or other caustic material, may lead to local tissue necrosis, granulomas, failure to deliver therapy, need for additional surgery to replace implanted port